PATENT CLAIM ANALYSIS

Application Number: 15979720
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "04400R"]

Abstract:
The present disclosure is directed to adeno -associated viral vector monoclonal antibody constructs and compositions thereof, methods of improving locomotor function after spinal cord injury, methods of treating neurodegenerative diseases.

Claim (Index 10):
A method of treating neurodegenerative disease in a subject in need thereof comprising the administration of at least one adeno-associated virus selected from the group consisting of AAV-rh10 and AAV-hu11 and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14818013', '15448946', '13508493', '12734016', '09530234']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7477706611162511
- 35 USC 102 Novelty (BERT): 0.6126778041520047
- Combined Prediction Score: 0.7342613754198265
- Mean Citation Score: 391.527258
- Max Citation Score: 650.41833
- Similarity Product: 449.7719177542841

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test